These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo. Zhang X; Chen J; Davis B; Kiechle F Arch Pathol Lab Med; 1999 Oct; 123(10):921-7. PubMed ID: 10506445 [TBL] [Abstract][Full Text] [Related]
3. Analysis of apoptosis by flow cytometry. Gorczyca W; Melamed MR; Darzynkiewicz Z Methods Mol Biol; 1998; 91():217-38. PubMed ID: 9664496 [No Abstract] [Full Text] [Related]
4. Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells. Gedik CM; Collins AR Nucleic Acids Res; 1990 Feb; 18(4):1007-13. PubMed ID: 2156221 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis induced with different cycle-perturbing agents produces differential changes in the fluorescence lifetime of DNA-bound ethidium bromide. Sailer BL; Valdez JG; Steinkamp JA; Crissman HA Cytometry; 1998 Mar; 31(3):208-16. PubMed ID: 9515720 [TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis within T lymphoblastoid cells by a topoisomerase I inhibitor. Johnson N; Ng TC; Parkin JM Biochem Soc Trans; 1997 May; 25(2):240S. PubMed ID: 9191284 [No Abstract] [Full Text] [Related]
11. A novel apoptosis research method with imaging-combined flow cytometer and HITC or IR-125 staining. Wang FS; Kubota F Cytometry; 2002 Oct; 50(5):267-74. PubMed ID: 12360577 [TBL] [Abstract][Full Text] [Related]
12. Cell-cycle analysis of drug-treated cells. Traganos F; Juan G; Darzynkiewicz Z Methods Mol Biol; 2001; 95():229-40. PubMed ID: 11089235 [No Abstract] [Full Text] [Related]
13. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Bedner E; Smolewski P; Amstad P; Darzynkiewicz Z Exp Cell Res; 2000 Aug; 259(1):308-13. PubMed ID: 10942603 [TBL] [Abstract][Full Text] [Related]
14. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Gorczyca W; Bigman K; Mittelman A; Ahmed T; Gong J; Melamed MR; Darzynkiewicz Z Leukemia; 1993 May; 7(5):659-70. PubMed ID: 8483318 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Bertrand R; Solary E; Jenkins J; Pommier Y Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316 [TBL] [Abstract][Full Text] [Related]
16. Apoptotic pathways depend on the target enzymatic activity and not on the triggering agent. Luchetti F; Mariani AR; Columbaro M; Di Baldassarre A; Cinti C; Falcieri E Scanning; 1999; 21(1):29-35. PubMed ID: 10070781 [TBL] [Abstract][Full Text] [Related]
18. Cleavage of Poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis. Li X; Darzynkiewicz Z Exp Cell Res; 2000 Feb; 255(1):125-32. PubMed ID: 10666341 [TBL] [Abstract][Full Text] [Related]
19. There is substantial nuclear and cellular disintegration before detectable phosphatidylserine exposure during the camptothecin-induced apoptosis of HL-60 cells. King MA; Radicchi-Mastroianni MA; Wells JV Cytometry; 2000 May; 40(1):10-8. PubMed ID: 10754512 [TBL] [Abstract][Full Text] [Related]
20. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies. Shimizu T; Pommier Y Exp Cell Res; 1996 Aug; 226(2):292-301. PubMed ID: 8806433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]